Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The paste without CPP-ACP is a placebo control formulation used in clinical research, specifically in studies conducted by Thammasat University to evaluate the efficacy of Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP) in preventing dental caries. It is formulated to be physically and sensorially identical to the active 10% w/v CPP-ACP paste (commercially known as Tooth Mousse) but lacks the active remineralizing complex. In the context of a randomized trial involving high-risk Thai preschool children, the paste was applied daily following fluoride toothbrushing to determine if the addition of CPP-ACP provides superior protection against the development of new carious lesions in primary teeth.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on the paste without CPP-ACP.